TLE6 play a pivotal role in modulating its phosphorylation state and consequent activation through diverse signaling pathways. Phorbol 12-myristate 13-acetate (PMA) functions as a potent activator of protein kinase C (PKC), which in turn can phosphorylate TLE6, thereby enhancing its interaction with other proteins and leading to its activation within the PKC-mediated signaling cascade. Similarly, 1,2-Dioctanoyl-sn-glycerol (DiC8), a diacylglycerol analog, also targets PKC, resulting in the phosphorylation and activation of TLE6. Ionomycin, by increasing intracellular calcium levels, can activate calcium-sensitive kinases that potentially modify TLE6, integrating it into calcium-dependent signaling mechanisms. Additionally, Epidermal Growth Factor (EGF) binds to its receptor, initiating a kinase cascade that includes MAPK and PI3K, which are known to phosphorylate TLE6 in the context of the EGF signaling pathway.
Forskolin, by elevating intracellular cAMP levels, activates protein kinase A (PKA), which can also lead to the phosphorylation and activation of TLE6. Isoproterenol, acting through beta-adrenergic receptors, raises cAMP and engages PKA, following a similar route to activate TLE6. Dibutyryl-cAMP, a cAMP analog, mirrors this route by directly activating PKA, reinforcing the cAMP-dependent pathway's role in TLE6 activation. Anisomycin, through its role as a JNK activator, influences the activity of TLE6 via the JNK signaling pathways. Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases like PP1 and PP2A, lead to an increase in the phosphorylation of proteins, including TLE6, by preventing their dephosphorylation. Phosphatidic Acid acts as a secondary messenger to activate PKC, subsequently affecting TLE6 phosphorylation. Lastly, Oleoyl-L-carnitine engages peroxisome proliferator-activated receptors (PPARs) to modulate the phosphorylation status of proteins, which includes the alteration of TLE6 activity in the PPAR signaling pathway. Each of these chemicals, through their distinctive mechanisms, converge on the regulation of TLE6, underscoring the complexity of cellular signaling networks in controlling protein function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to the phosphorylation and activation of TLE6 by enhancing its interaction with other regulatory proteins in the PKC-mediated signaling pathway. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium-sensitive kinases and phosphatases that modify TLE6, resulting in its functional activation through calcium signaling pathways. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8 is an analog of diacylglycerol (DAG) that activates PKC; PKC can subsequently phosphorylate TLE6, resulting in the activation of TLE6 as part of the DAG-PKC signaling axis. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol acts as an agonist for beta-adrenergic receptors, leading to increased cAMP and activation of PKA, which can phosphorylate and activate TLE6 within the adrenergic signaling pathway. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can lead to the activation of AP-1 transcription factor, influencing the phosphorylation state and activity of TLE6 through JNK signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins, potentially including TLE6, thereby activating TLE6 through reduced dephosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA, which in turn can phosphorylate and activate TLE6 as part of the cAMP/PKA signaling pathway. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases, leading to an increase in protein phosphorylation, which could include TLE6, thus activating TLE6 through inhibition of its dephosphorylation. | ||||||